Markets
markets

Palantir up early after Friday’s late-day plunge

Retail favorite, top S&P 500 gainer, and Trump stock par excellence Palantir is up early after a partnership deal was announced with Accenture Federal Services centering on Palantir’s growing AI software business with Uncle Sam.

Essentially, Palantir will train and certify some 1,000 Accenture employees, who will install and help implement the company’s AI software packages throughout the federal government.

The deal could offer some real benefits to the way Palantir interacts with its single largest customer: the US federal government.

That relationship appears to be expanding rapidly under the Trump administration. But the increasing linkages are raising concerns both about threats to the privacy of American citizens as well as the character of the company’s leadership and the potential influence of the Palantir’s cofounder and largest individual shareholder, Peter Thiel. The Republican megadonor and right-wing ideologue famously penned a personal statement for the Cato Institute in 2009 in which he declared, “I no longer believe that freedom and democracy are compatible.”

Just this morning, liberal American economist Robert Reich published a piece with the not particularly subtle headline, “Peter Thiel’s Palantir poses a grave threat.” The concern is not just among the liberal left, either — bro-centric podcaster Theo Von also says of Palantir, “I’m scared of it.”

Bad press doesn’t seem to pose much of a threat to the business at the moment, but the company’s federal contracting business could come in for closer scrutiny should Democrats retake control of one or perhaps both houses of Congress in next year’s midterms.

For a Palantir executive called to testify about its operations, one could imagine the utility of being able to say the software was installed and implemented by a seasoned, sleepy federal contracting company like Accenture, a potentially comforting factor for elected officials.

At any rate, the market seems to like the deal, helping the shares claw back some of the losses seen in a waterfall finish to trading last week. With few obvious catalysts, Palantir plunged in the last 10 minutes of trading Friday, pushing its losses from about 4% to more than 9%.

The deal could offer some real benefits to the way Palantir interacts with its single largest customer: the US federal government.

That relationship appears to be expanding rapidly under the Trump administration. But the increasing linkages are raising concerns both about threats to the privacy of American citizens as well as the character of the company’s leadership and the potential influence of the Palantir’s cofounder and largest individual shareholder, Peter Thiel. The Republican megadonor and right-wing ideologue famously penned a personal statement for the Cato Institute in 2009 in which he declared, “I no longer believe that freedom and democracy are compatible.”

Just this morning, liberal American economist Robert Reich published a piece with the not particularly subtle headline, “Peter Thiel’s Palantir poses a grave threat.” The concern is not just among the liberal left, either — bro-centric podcaster Theo Von also says of Palantir, “I’m scared of it.”

Bad press doesn’t seem to pose much of a threat to the business at the moment, but the company’s federal contracting business could come in for closer scrutiny should Democrats retake control of one or perhaps both houses of Congress in next year’s midterms.

For a Palantir executive called to testify about its operations, one could imagine the utility of being able to say the software was installed and implemented by a seasoned, sleepy federal contracting company like Accenture, a potentially comforting factor for elected officials.

At any rate, the market seems to like the deal, helping the shares claw back some of the losses seen in a waterfall finish to trading last week. With few obvious catalysts, Palantir plunged in the last 10 minutes of trading Friday, pushing its losses from about 4% to more than 9%.

More Markets

See all Markets
markets

Bullish options flows boost Rivian

EV maker Rivian is up nearly 5% on Monday afternoon as bullish options flows lift the stock ahead of its third-quarter earnings, set to drop next week.

According to Bloomberg, Rivian call options traded outnumber put options more than five to one, for a put/call ratio of less than 0.2 as of 2:38 p.m. ET. That’s significantly less than the 20-day put/call average of 0.4. More than 116,000 call options have changed hands, more than 60% above the full-day average over the past 20 days.

Rivian’s upcoming earnings will measure the automaker’s sales ahead of the expiration of the $7,500 EV tax credit. Since September, Rivian has performed two rounds of layoffs as it seeks to cut costs amid the end of regulatory credits and ahead of next year’s lower-cost SUV launch.

markets

Palantir inks defense deal with Poland, touches new intraday high

Palantir Technologies touched a new intraday high of $192.83 early Monday, as the company rode the China trade truce rally in AI tech stocks and retail favorites.

Palantir also signed a new deal to supply the government of Poland with data, AI, and cybersecurity software, according to Bloomberg.

Polish Minister of Defense Wladyslaw Kosiniak-Kamysz and Palantir CEO Alex Karp signed the letter of intent on the deal, about which few details were released. Polish officials did signal that they were interested in Palantir software systems for “battlefield management” and logistics. Up more than 150% this year, Palantir reports Q3 earnings on November 3.

Polish Minister of Defense Wladyslaw Kosiniak-Kamysz and Palantir CEO Alex Karp signed the letter of intent on the deal, about which few details were released. Polish officials did signal that they were interested in Palantir software systems for “battlefield management” and logistics. Up more than 150% this year, Palantir reports Q3 earnings on November 3.

markets

Intellia tanks as it pauses late-stage CRISPR gene-editing trials after one patient was hospitalized

Intellia dropped sharply on Monday after it announced that it’s pausing two late-stage CRISPR gene-editing trials because one patient was hospitalized with liver damage.

Intellia had also disclosed in May that a patient had experienced elevated liver enzymes. The news is a major setback for the company, which currently has no products on the market and is working on a one-time treatment for heart and nerve conditions.

The news dragged down other companies working on CRISPR treatments, including Beam Therapeutics Inc, Crispr Therapeutics, Editas Medicine, and Prime Medicine.

markets

Gold craters as retail traders pull money from commodity ETFs

As its fierce rally begins to fade, it looks like retail traders are waving au revoir to gold.

JPMorgan strategist Arun Jain noted that retail traders have pulled about $120 million from commodity ETFs as of 11 a.m. ET on Monday, a level that stands in the 0.4th percentile relative to its one-year average. The SPDR Gold Shares ETF is down 2.8% as of 11:53 a.m. ET after suffering its worst loss since April 2013 last Tuesday. That day, retail had pulled just $50 million from commodity ETFs by 11 a.m.

The five-session average daily flows into the product hit an all-time high of nearly $1.1 billion last Monday as gold and silver had effectively become the new meme stocks, displaying strong momentum and heavy options activity.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.